查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571948

全球生物義肢市場

Bioprosthetics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 92 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球生物義肢市場將達到 119 億美元

2023年全球生物義肢市場估計為63億美元，預計2030年將達到119億美元，2023-2030年分析期間複合年成長率為9.5%。異種移植生物假體是本報告分析的細分市場之一，預計複合年成長率為 10.0%，到分析期結束時將達到 83 億美元。在分析期間，同種異體移植生物假體部分的複合年成長率估計為 8.4%。

美國市場預計16億美元，中國預計複合年成長率14.1%

到 2023 年，美國生物義肢市場預計將達到 16 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達31億美元，2023-2030年分析期間複合年成長率為14.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.9% 和 8.5%。在歐洲，德國的複合年成長率預計約為 5.9%。

全球生物農藥市場－主要趨勢與促進因素總結

生物農藥如何徹底改變農業？

生物農藥正成為現代農業的遊戲規則改變者，為傳統化學農藥提供永續且環保的替代方案。這些農藥源自天然或生物來源，例如微生物、植物抽取物和其他有機化合物，以更特異性、更環保的方式針對害蟲。生物農藥旨在有效控制害蟲、疾病和雜草，同時最大限度地減少對環境的負面影響。它們因其對人類、有益昆蟲和野生動物等非目標生物體的低毒性而越來越受歡迎。隨著世界對永續農業的日益關注以及對有機農產品的需求不斷成長，生物農藥已成為害蟲綜合治理 (IPM) 計劃的重要組成部分。這些產品不僅保護農作物，也支持生物多樣性和土壤健康，使其成為農民平衡生產力與生態責任的重要工具。隨著農業產業面臨越來越大的減少化學農藥使用的監管壓力，生物農藥為保護作物產量和環境提供了可行的解決方案。

最終用途如何影響生物農藥的採用？

生物農藥在各個農業領域的應用正在迅速擴大，其中水果、蔬菜和特種作物是需求的主要驅動力。這些作物通常對病蟲害高度敏感，並從作為精密農業策略一部分的生物農藥的針對性作用中受益匪淺。例如，有機和永續農民擴大使用生物農藥、殺蟲劑、殺菌劑和除草劑來防治病蟲害，而不損害其有機資質。在園藝領域，生物處理產品廣泛用於保護觀賞植物和草坪，為公共空間、公園和高爾夫球場提供更安全的替代方案。此外，這些殺蟲劑在公共衛生領域的媒介傳播疾病管理方面正在取得進展，其中控制蚊子和其他攜帶疾病的昆蟲非常重要。除田間作物外，生物農藥也應用於溫室栽培。由於溫室栽培的受控環境，保持害蟲防治和植物健康之間的平衡非常重要。生物農藥在不同領域的使用日益增多，凸顯了它們的多功能性和在現代農業中日益成長的重要性。

科技在生物農藥的進步中扮演什麼角色？

技術進步在提高生物農藥的有效性和應用方面發揮著重要作用，使農民更可靠、更容易獲得它們。先進發酵和配方技術的發展提高了微生物生物農藥的穩定性、保存期限和功效，使其在農業中廣泛採用。此外，無人機和感測器技術等精密農業技術創新使得生物農藥的散佈更有針對性，減少浪費並確保只在需要的地方進行處理。這種精確度不僅提高了害蟲防治的效率，也減少了農藥使用的整體環境足跡。此外，生物技術的進步正在開發基因工程生物農藥，這些農藥對有益生物體更安全，但對抗性害蟲更有效。這些創新加上人工智慧驅動的預測模型，可以實現更好的害蟲監測和精確的農藥散佈時間，以最大限度地提高其有效性。此外，數位農業工具和生物農藥散佈的日益一體化將使農民能夠採用更永續的害蟲管理方法，這符合資料主導農業的全球趨勢。

推動生物農藥市場成長的因素有哪些？

生物農藥市場的成長受到多種因素的推動，例如對永續農業方法的需求增加、對化學農藥使用的嚴格規定以及消費者對有機食品和無農藥殘留食品的偏好的改變。主要促進因素之一是人們對合成化學農藥相關環境和健康風險的認知不斷提高，促使消費者和政府尋求更安全的替代方案。主要農業經濟體的監管機構正在加強對傳統農藥使用的監管，導致生物農藥產品的採用增加。此外，消費者對有機和永續種植食品的需求不斷增加也鼓勵農民將生物農藥納入其害蟲管理策略的一部分。另一個因素是害蟲對化學農藥的抗藥性日益普遍，這使得具有新穎作用方式的生化解決方案成為更具吸引力的選擇。生物技術和配方技術的創新也透過提高這些產品的功效和保存期限來促進市場成長。此外，綜合害蟲管理 (IPM) 計劃在傳統農業和有機農業中的擴展正在推動對生物農藥的需求，作為 IPM 強調的永續和有針對性的方法的補充。隨著農業部門繼續優先考慮永續性和生產力，生物農藥市場預計將穩定成長。

受訪企業範例（36家知名企業）

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP21347

Global Bioprosthetics Market to Reach US$11.9 Billion by 2030

The global market for Bioprosthetics estimated at US$6.3 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 9.5% over the analysis period 2023-2030. Xenograft Bioprosthetics, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in the Allograft Bioprosthetics segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 14.1% CAGR

The Bioprosthetics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global Biorational Pesticides Market – Key Trends & Drivers Summarized

How Are Biorational Pesticides Revolutionizing Agriculture?

Biorational pesticides are emerging as a game-changer in modern agriculture, offering a sustainable and environmentally friendly alternative to traditional chemical pesticides. These pesticides, derived from natural or biological origins such as microorganisms, plant extracts, or other organic compounds, target pests in a more specific and eco-friendly manner. Biorational pesticides are designed to minimize negative environmental impacts while effectively controlling pests, diseases, and weeds. They are gaining popularity due to their reduced toxicity to non-target organisms, including humans, beneficial insects, and wildlife. With the increasing global focus on sustainable agriculture and the growing demand for organic produce, biorational pesticides are becoming an integral part of Integrated Pest Management (IPM) programs. These products not only help protect crops but also support biodiversity and soil health, making them a critical tool for farmers seeking to balance productivity with ecological responsibility. As the agricultural industry faces increasing regulatory pressures to reduce chemical pesticide use, biorational pesticides offer a viable solution to safeguard both crop yields and the environment.

How Are End-Use Applications Shaping the Adoption of Biorational Pesticides?

The application of biorational pesticides is expanding rapidly across various agricultural sectors, with fruits, vegetables, and specialty crops being key drivers of demand. These crops, which are often highly sensitive to pests and diseases, benefit significantly from the targeted action of biorational pesticides, which are applied as part of precision agriculture strategies. For example, organic and sustainable farmers are increasingly adopting biorational insecticides, fungicides, and herbicides to manage pests and diseases without compromising their organic certification. In horticulture, biorational products are widely used to protect ornamentals and turf, offering a safer alternative for public spaces, parks, and golf courses. Additionally, these pesticides are gaining traction in the management of vector-borne diseases in public health, where controlling mosquitoes and other disease-carrying insects is critical. Beyond field crops, biorational pesticides are finding applications in greenhouse cultivation, where maintaining a balance between pest control and plant health is crucial due to the controlled environment. The expanding use of biorational pesticides across diverse sectors highlights their versatility and growing importance in modern agriculture.

What Role Does Technology Play in Advancing Biorational Pesticides?

Technological advancements are playing a crucial role in enhancing the effectiveness and application of biorational pesticides, making them more reliable and accessible for farmers. The development of advanced fermentation and formulation technologies has improved the stability, shelf-life, and potency of microbial-based biorational products, enabling their broader adoption in agriculture. Additionally, innovations in precision agriculture, such as drones and sensor technologies, are enabling more targeted application of biorational pesticides, reducing wastage and ensuring that the treatments are applied only where needed. This precision not only enhances pest control efficiency but also reduces the overall environmental footprint of pesticide usage. Furthermore, advancements in biotechnology have led to the creation of genetically engineered biopesticides that are more effective against resistant pests while remaining safe for beneficial organisms. These innovations, along with AI-driven predictive models, allow for better pest monitoring and more accurate timing of pesticide applications, maximizing their efficacy. The growing integration of digital farming tools with biorational pesticide application is also helping farmers adopt more sustainable pest management practices, aligning with global trends toward data-driven agriculture.

What Factors Are Driving Growth in the Biorational Pesticides Market?

The growth in the biorational pesticides market is driven by several factors, including increased demand for sustainable farming practices, stringent regulations on chemical pesticide use, and shifting consumer preferences towards organic and residue-free food. One of the key drivers is the growing awareness of the environmental and health risks associated with synthetic chemical pesticides, prompting both consumers and governments to seek safer alternatives. Regulatory bodies in major agricultural economies are tightening restrictions on the use of traditional pesticides, leading to increased adoption of biorational products. Furthermore, the rising consumer demand for organic and sustainably grown food is pushing farmers to embrace biorational pesticides as part of their pest management strategy. Another factor is the increasing prevalence of pest resistance to chemical pesticides, which has made biorational solutions, with their novel modes of action, a more attractive option. Technological innovations in biotechnology and formulation techniques are also contributing to market growth by improving the efficacy and shelf-life of these products. Additionally, the expansion of Integrated Pest Management (IPM) programs in both conventional and organic farming is driving the demand for biorational pesticides, as they complement the sustainable and targeted approach that IPM emphasizes. As the agricultural sector continues to prioritize sustainability and productivity, the market for biorational pesticides is expected to grow steadily.

Select Competitors (Total 36 Featured) -

  • Aortech International Plc
  • Braile Biomedica, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Ethicon, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular, Inc.
  • LifeCell International

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bioprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Propels Demand for Bioprosthetic Heart Valves
    • Technological Advancements in Tissue Engineering Drive Innovation in Next-Generation Bioprosthetics
    • Growing Preference for Minimally Invasive Surgeries Spurs Adoption of Bioprosthetic Implants
    • Increasing Use of Bioprosthetic Materials in Orthopedic Applications Expands the Addressable Market
    • Improved Biocompatibility and Longevity of Bioprosthetics Strengthens Their Adoption in Cardiovascular and Orthopedic Surgeries
    • Growing Focus on Customized Bioprosthetic Solutions for Personalized Medicine Creates New Market Opportunities
    • Rising Demand for Aesthetic and Functional Bioprosthetics in Reconstructive Surgeries Drives Market Growth
    • Advances in Xenotransplantation Technologies Expand the Development and Adoption of Bioprosthetic Devices
    • Increasing R&D in Biomaterials and Biopolymer Technologies Propels Innovation in Bioprosthetic Design
    • Favorable Reimbursement Policies in Developed Markets Drive Adoption of Bioprosthetic Implants in Healthcare Systems
    • Growing Role of 3D Printing in Manufacturing Custom Bioprosthetics Expands Opportunities for Personalized Implants
    • Increasing Incidence of Sports Injuries and Trauma Surgeries Generates Demand for Bioprosthetic Ligaments and Tendons
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bioprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Xenograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Xenograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Allograft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Allograft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Plastic Surgery & Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Plastic Surgery & Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Bioprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • JAPAN
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • CHINA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • EUROPE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioprosthetics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • FRANCE
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • GERMANY
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioprosthetics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • INDIA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: India 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioprosthetics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioprosthetics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Bioprosthetics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030
  • AFRICA
    • Bioprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Type - Xenograft and Allograft - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioprosthetics by Type - Xenograft and Allograft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Bioprosthetics by Type - Percentage Breakdown of Value Sales for Xenograft and Allograft for the Years 2014, 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioprosthetics by Application - Cardiovascular and Plastic Surgery & Wound Healing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Bioprosthetics by Application - Percentage Breakdown of Value Sales for Cardiovascular and Plastic Surgery & Wound Healing for the Years 2014, 2024 & 2030

IV. COMPETITION